12,500 Shares in SPDR S&P Biotech ETF $XBI Bought by Y.D. More Investments Ltd

Y.D. More Investments Ltd acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) in the 4th quarter, Holdings Channel reports. The firm acquired 12,500 shares of the exchange traded fund’s stock, valued at approximately $1,524,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Compass Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF in the third quarter worth about $1,167,000. China Universal Asset Management Co. Ltd. raised its position in SPDR S&P Biotech ETF by 868.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after purchasing an additional 4,411 shares during the period. Ashton Thomas Private Wealth LLC purchased a new stake in SPDR S&P Biotech ETF during the third quarter valued at approximately $417,000. Altfest L J & Co. Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 63.1% in the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock valued at $12,517,000 after purchasing an additional 48,326 shares during the last quarter. Finally, Brian Low Financial Group LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $668,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $128.96 on Monday. The business’s 50 day moving average price is $125.00 and its 200-day moving average price is $118.56. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $132.09. The company has a market cap of $7.51 billion, a P/E ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Recommended Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.